Rxsight IncNASDAQ:RXST
- LAST PRICE14.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots12.2000/ 10
- Ask / Lots14.4000/ 1
- Open / Previous Close13.9600 / 14.0000
- Day Range
- 52 Week Range
- Volume46,509
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RXST |
|---|---|---|
| 09:33 ET | 300 | 13.96 |
| 09:37 ET | 736 | 13.9 |
| 09:39 ET | 2386 | 13.9 |
| 09:42 ET | 1706 | 13.9 |
| 09:48 ET | 298 | 13.82 |
| 10:51 ET | 2148 | 13.99 |
| 10:54 ET | 583 | 14.025 |
| 11:05 ET | 200 | 14.07 |
| 11:12 ET | 100 | 14.21 |
| 11:14 ET | 700 | 14.16 |
| 11:32 ET | 150 | 14.1745 |
| 11:45 ET | 1000 | 14 |
| 11:52 ET | 300 | 14 |
| 11:54 ET | 800 | 14 |
| 11:57 ET | 600 | 14 |
| 12:03 ET | 200 | 13.99 |
| 12:06 ET | 100 | 13.92 |
| 12:39 ET | 100 | 13.845 |
| 01:29 ET | 100 | 13.76 |
| 01:33 ET | 100 | 13.88 |
| 02:12 ET | 100 | 13.92 |
| 02:14 ET | 100 | 13.98 |
| 02:18 ET | 149 | 13.94 |
| 02:34 ET | 200 | 13.94 |
| 02:41 ET | 1500 | 13.99 |
| 02:43 ET | 152 | 14 |
| 02:52 ET | 100 | 13.945 |
| 02:57 ET | 100 | 13.99 |
| 03:01 ET | 200 | 13.97 |
| 03:12 ET | 200 | 13.96 |
| 03:15 ET | 900 | 13.9 |
| 03:17 ET | 500 | 13.9 |
| 03:21 ET | 520 | 13.98 |
| 03:32 ET | 100 | 14 |
| 03:46 ET | 200 | 13.99 |
| 03:48 ET | 100 | 14 |
| 03:51 ET | 200 | 14 |
| 03:53 ET | 200 | 14 |
| 03:55 ET | 500 | 13.98 |
| 03:57 ET | 100 | 14 |
Jan 9, 2023
RxSight Reports Preliminary Q4, Full-Year 2022 Revenue Growth, from 5:36AM ET on Monday Jan 09, 2023 by MT Newswires
5:36AM ET on Monday Jan 09, 2023 by MT Newswires
Jan 8, 2023
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results, from 4:00PM ET on Sunday Jan 08, 2023 by GlobeNewswire
4:00PM ET on Sunday Jan 08, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Rxsight Inc | 382.8M | -5.8x | --- |
Pulmonx Corp | 328.8M | -5.7x | --- |
CVRx Inc | 300.8M | -7.5x | --- |
Utah Medical Products Inc | 323.7M | 21.0x | +4.64% |
Surmodics Inc | 394.1M | -14.4x | --- |
IRadimed Corp | 461.2M | 36.2x | +4.24% |
Company Information
RxSight, Inc. is a commercial-stage medical technology company. The Company is engaged in improving the vision of patients following cataract surgery. Its RxSight Light Adjustable Lens system (RxSight system), comprised of its RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and accessories, is the intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. Its LAL is made of photosensitive material that changes shape in response to patterns of ultraviolet (UV) light generated by its LDD. Its RxSight system helps surgeon to performs a standard cataract procedure to implant the LAL, and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes. Alternative IOL technologies, are not adjustable following the surgery and therefore require patients to make pre-operative choices about their visual preferences.
Contact Information
- Headquarters
- 100 COLUMBIA STREET, SUITE 120ALISO VIEJO, CA, United States 92656
- Phone
- 949-521-7822
- Fax
- ---
Executives
- Independent Director
- Andy Corley
- President, Chief Executive Officer
- Ron Kurtz
- Chief Financial Officer
- Shelley Thunen
- Chief Operating Officer
- Ilya Goldshleger
- Chief Commercial Officer
- Eric Weinberg
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $382.8M |
|---|---|
Revenue (TTM) | $41.3M |
Shares Outstanding | 27.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.43 |
Book Value | $5.05 |
P/E Ratio | -5.8x |
Price/Sales (TTM) | 9.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -152.36% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
